Cargando…

Akt inhibition improves long‐term tumour control following radiotherapy by altering the microenvironment

Radiotherapy is an important anti‐cancer treatment, but tumour recurrence remains a significant clinical problem. In an effort to improve outcomes further, targeted anti‐cancer drugs are being tested in combination with radiotherapy. Here, we have studied the effects of Akt inhibition with AZD5363....

Descripción completa

Detalles Bibliográficos
Autores principales:	Searle, Emma J, Telfer, Brian A, Mukherjee, Debayan, Forster, Duncan M, Davies, Barry R, Williams, Kaye J, Stratford, Ian J, Illidge, Tim M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709765/ https://www.ncbi.nlm.nih.gov/pubmed/29084756 http://dx.doi.org/10.15252/emmm.201707767

Ejemplares similares

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
por: Colton, Madyson, et al.
Publicado: (2020)

Understanding the Effects of Radiotherapy on the Tumour Immune Microenvironment to Identify Potential Prognostic and Predictive Biomarkers of Radiotherapy Response
por: Cheng, Shuhui, et al.
Publicado: (2020)

Hypoxia and oxidative stress in breast cancer: Tumour hypoxia – therapeutic considerations
por: Williams, Kaye J, et al.
Publicado: (2001)

The effect of hypoxia on PD-L1 expression in bladder cancer
por: Smith, Vicky, et al.
Publicado: (2021)

ZD1839 (‘Iressa’), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model
por: Williams, K J, et al.
Publicado: (2002)

Radiation enhances the therapeutic effect of Banoxantrone in hypoxic tumour cells with elevated levels of nitric oxide synthase
por: MEHIBEL, MANAL, et al.
Publicado: (2016)

Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1
por: Mukherjee, Debayan, et al.
Publicado: (2023)

The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy
por: Frankish, Jamie, et al.
Publicado: (2023)

Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate Cancer
por: Haughey, Charles M., et al.
Publicado: (2020)

17β-Oestradiol treatment modulates nitric oxide synthase activity in MDA231 tumour with implications on growth and radiation response
por: Chinje, E C, et al.
Publicado: (2002)

Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent
por: Patterson, L H, et al.
Publicado: (2000)

Neuroendocrine tumours and their microenvironment
por: de Hosson, Lotte D., et al.
Publicado: (2020)

Pretreatment apoptosis in carcinoma of the cervix correlates with changes in tumour oxygenation during radiotherapy
por: Sheridan, M T, et al.
Publicado: (2000)

Glucocorticoid receptor over-expression promotes human small cell lung cancer apoptosis in vivo and thereby slows tumor growth
por: Sommer, Paula, et al.
Publicado: (2010)

A novel systemically administered toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models
por: Adlard, Amy L, et al.
Publicado: (2014)

The role of the tumour microenvironment in the angiogenesis of pituitary tumours
por: Marques, Pedro, et al.
Publicado: (2020)

Radiotherapy and the tumor microenvironment: The “macro” picture
por: Walton, Emma Louise
Publicado: (2017)

Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model
por: Philippou, Yiannis, et al.
Publicado: (2020)

Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
por: Marques, Pedro, et al.
Publicado: (2019)

Imaging the tumour microenvironment in rectal cancer: Decline in tumour blood flow during radiotherapy predicts good outcome
por: Bakke, Kine Mari, et al.
Publicado: (2023)

The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy
por: Lunt, S J, et al.
Publicado: (2010)

Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer
por: Smith, Vicky, et al.
Publicado: (2022)

Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters
por: Mehibel, Manal, et al.
Publicado: (2018)

Adrenomedullin and tumour microenvironment
por: Larráyoz, Ignacio M, et al.
Publicado: (2014)

The hypoxic tumour microenvironment
por: Petrova, Varvara, et al.
Publicado: (2018)

Beyond the tumour microenvironment
por: Laplane, Lucie, et al.
Publicado: (2019)

Functional Roles for Exosomal MicroRNAs in the Tumour Microenvironment
por: Bell, Emma, et al.
Publicado: (2016)

Mitochondrial Retrograde Signalling and Metabolic Alterations in the Tumour Microenvironment
por: Yang, Dongki, et al.
Publicado: (2019)

In vitro cytotoxic drug sensitivity testing of human tumour xenografts grown as multicellular tumour spheroids.
por: Jones, A. C., et al.
Publicado: (1982)

Mechanisms of action of tasquinimod on the tumour microenvironment
por: Raymond, E., et al.
Publicado: (2013)

Photoacoustic imaging as a tool to probe the tumour microenvironment
por: Brown, Emma, et al.
Publicado: (2019)

Radiotherapy transiently reduces the sensitivity of cancer cells to lymphocyte cytotoxicity
por: Tuomela, Karoliina, et al.
Publicado: (2022)

Opticin: a potent anti-angiogenic/antiproliferative agent for breast cancer therapy
por: Sneddon, SF, et al.
Publicado: (2010)

Nanomotors Sense Local Physicochemical Heterogeneities in Tumor Microenvironments
por: Dasgupta, Debayan, et al.
Publicado: (2020)

Bioreductive drugs and the selective induction of tumour hypoxia.
por: Bremner, J. C., et al.
Publicado: (1990)

The Role of CDK5 in Tumours and Tumour Microenvironments
por: Do, Phuong Anh, et al.
Publicado: (2020)

Vascular normalisation as the stepping stone into tumour microenvironment transformation
por: Magnussen, Anette L., et al.
Publicado: (2021)

Enhancement of bioreductive drug toxicity in murine tumours by inhibition of the activity of nitric oxide synthase.
por: Butler, S. A., et al.
Publicado: (1997)

Defining the tumour and target volumes for radiotherapy
por: Burnet, Neil G, et al.
Publicado: (2004)

Radiotherapy–Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery?
por: Romano, Erminia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k3enb7vmmco5e171pd3mif7alk